NCT03625674

Impact of Stigma on Compliance to Medication in Functional Dyspepsia

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 220 (estimated)
• Sponsor: RenJi Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

To date, no study exists that evaluates whether functional dyspepsia patients experience stigma and how stigma may influence adherence. Thus, the investigators aim to evaluate the relationship between functional dyspepsia and stigma, and explore possible ways to improve treatment adherence.

Detailed description

Due to the functional but refractory nature of functional gastrointestinal diseases (FGIDs), large number of patients who suffer from FGIDs may not be able to fully understand their diagnosis, especially when they were told that they had no organic disease and their symptoms had a psychosomatic origin rather than a gastrointestinal one. Moreover, subjects with FGIDs have concerns and negative perceptions about medications, particularly in the presence of psychiatric comorbidity. Fearing of being labeled as insane or incapability, many patients with psychosomatic symptoms choose to conceal their illness to family, colleagues and doctors. These factors may affect willingness to initiate neuromodulator regimens and treatment adherence.

Conditions

• Functional Gastrointestinal Disorders
• Adherence, Patient

Interventions

Type	Name	Description
BEHAVIORAL	explanation when prescribing psychoactive medicine	explanation of the pathogenesis of FD and the mechanism of psychoactive medicine

Timeline

• Start date: 2017-09-01
• Primary completion: 2021-12-31
• Completion: 2021-12-31
• First posted: 2018-08-10
• Last updated: 2021-03-10

Locations

1 site across 1 country: China